Insider Trends: Insider at Bristol-Myers Squibb Acquires Stock Via Conversion of Option/Derivative Security Sells Portion to Pay Tax, Buy Trend Intact
04:41 PM EDT, 05/11/2021 (MT Newswires) -- On May 08, 2021, Dr Rupert Vessey, EVP, Research & Early Dev., exercised options/derivative securities for 17,245 shares of Bristol-Myers Squibb (BMY) and sold 7,994 shares in the company for $515,133 to meet tax obligations. After accounting for tax obligations this transaction resulted in a net acquisition of 9,251 company shares. Following the Form 4 filing with the SEC, Dr Vessey controls 55,008 company shares of which 54,390 shares are held directly and 618 are owned indirectly. These holdings have an approximate market value of $3.56 million as of the prior-day closing price.
In the 90 days prior to the date of this filing, there have been 15 insider transactions reported to the SEC for Bristol-Myers Squibb. These transactions came from the activities of 13 individual insiders that resulted in a net acquisition of 161,226 company shares. In the preceding 90-day window of time, there were 24 transactions from 7 insiders which resulted in the net acquisition of 5,692 shares.
This is a lower level of transactions than the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Peer group activity averaged 64.5 transactions per company, and disposition of 7,234 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/14272/000001427221000134/xslF345X03/wf-form4_162076551113132.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.